Attributes | Values |
---|
rdf:type
| |
Description
| - Mesalazine, which can be administered in various galenical form..The study compared a new form of mesalazine pellets in the form of prolonged-release mesalazine with the conventional form of the tablet. At the same time monitored the effectiveness of increasing the dose of mesalazine in both treatment groups. The study randomized 233 patients with mild to moderate UC.Mesalazine pellets were as effective as tablets and escalation (increase) the dose is justified option for patients who are at half the initial dose did not respond.
- Mesalazine, which can be administered in various galenical form..The study compared a new form of mesalazine pellets in the form of prolonged-release mesalazine with the conventional form of the tablet. At the same time monitored the effectiveness of increasing the dose of mesalazine in both treatment groups. The study randomized 233 patients with mild to moderate UC.Mesalazine pellets were as effective as tablets and escalation (increase) the dose is justified option for patients who are at half the initial dose did not respond. (en)
|
Title
| - A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis
- A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis (en)
|
skos:prefLabel
| - A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis
- A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis (en)
|
skos:notation
| - RIV/61989592:15110/05:10223097!RIV12-MSM-15110___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/05:10223097
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - capsule; 5-ASA; olsalazin; sulfasalazine; kappa - B; clinical evaluation; 5-animosalicyl acid; Inflammatory Bowel Disease (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Procházka, Vlastimil
- Hůlek, P.
- Lukáš, M.
- Fixa, B.
- Stolte, M.
- Bátovský, M.
- Greinwald, R.
- Grigoryeva, G.
- Holomán, J.
- Marakhouski, Y.
- Rumyantsev, V.
|
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |